Skip to main content
. 2021 Aug 4;12:683809. doi: 10.3389/fgene.2021.683809

Figure 1.

Figure 1

MEG3, miRNA-29, and miRNA182 expression levels in serum. (A) Fold change in serum expression MEG3 level in patients with BC (n = 180) and fibroadenoma (n = 120) relative to healthy subjects (n = 150). (B) Fold change in serum expression miRNA-29 level in patients with BC (n = 180) and fibroadenoma (n = 120) compared with healthy subjects (n = 150). Values are expressed as mean ± SEM (95% CI). (C) Fold change of serum expression miRNA-182 level in patients with BC (n = 180) and fibroadenoma (n = 120) compared with healthy subjects (n = 150). *Significant difference from the control group at p < 0.05. #Significant difference from FA group at p < 0.05.